Nadereh Rashtchizadeh

Dr. Nadereh Rashtchizadeh


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
NANazi Aghaalikhani
Nazi Aghaalikhani
NRNadereh Rashtchizadeh
Nadereh Rashtchizadeh
PSPejman Shadpour
Pejman Shadpour
AAAbdolamir Abdolamir
Abdolamir Abdolamir
MMMarzieh Mahmoodi
Marzieh Mahmoodi

18 February 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
PSPejman Shadpour
Pejman Shadpour
MZMojtaba Zamani
Mojtaba Zamani
NANazi Aghaalikhani
Nazi Aghaalikhani
NRNadereh Rashtchizadeh
Nadereh Rashtchizadeh

1 April 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
NMNarmin Mokarizadeh
Narmin Mokarizadeh
PKPouran Karimi
Pouran Karimi
MEMarjan Erfani
Marjan Erfani
SSSaeed Sadigh-Eteghad
Saeed Sadigh-Eteghad
NMNazila Fathi Maroufi
Nazila Fathi Maroufi
NRNadereh Rashtchizadeh
Nadereh Rashtchizadeh

1 October 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
NMNarmin Mokarizadeh
Narmin Mokarizadeh
PKPouran Karimi
Pouran Karimi
HKHamid Kazemzadeh
Hamid Kazemzadeh
NMNazila Fathi Maroufi
Nazila Fathi Maroufi
SSSaeed Sadigh-Eteghad
Saeed Sadigh-Eteghad
NRNadereh Rashtchizadeh
Nadereh Rashtchizadeh

29 October 2018 in Modern Rheumatology
Verified
Journal Article
Closed access
AMAida Malek Mahdavi
Aida Malek Mahdavi
AKAlireza Khabbazi
Alireza Khabbazi
BYBarmak Yaaghoobian
Barmak Yaaghoobian
MGMorteza Ghojazadeh
Morteza Ghojazadeh
RARamin Agamohammadi
Ramin Agamohammadi
NRNadereh Rashtchizadeh
Nadereh Rashtchizadeh
Objective: Behcet’s disease (BD) is an inflammatory disease and smoking may have a role in its triggering. This case-control study was conducted to investigate the association between smoking and the risk of BD. Methods: We included 192 patients with BD and 822 healthy siblings of patient with BD and 373 healthy unrelated persons as control groups. Demographic data and smoking history of patients and their siblings were obtained by direct and in some cases by telephone interview with the participants. Demographic data and smoking history of healthy controls were obtained by direct interview. Propensity score matching (PSM) analyses for reducing the heterogeneity between studied groups and calculating the actual effect of smoking in BD was performed. Matching was performed based on demographic characteristics (age, gender, educational status and marital status). After PSM, we carried out multivariate analyses with BD as the main outcome variable and smoking history as the main predictor variable to calculate odds ratios with 95% confidence intervals. Results: Ever smoking was not significantly associated with an increased risk of BD compared with never smoking. In comparison with healthy siblings and healthy unrelated persons, the relative risk of developing BD was 0.8–2.6. No significant differences were observed in the clinical manifestations of BD patients in ever smokers and never smokers. However, disease activity in ever smokers at disease presentation was significantly more than never smokers. Conclusion: Smoking is not a significant risk factor for BD.

22 October 2019 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
MJMaryam Jabarpour
Maryam Jabarpour
NRNadereh Rashtchizadeh
Nadereh Rashtchizadeh
HAHassan Argani
Hassan Argani
AGAmir Ghorbanihaghjo
Amir Ghorbanihaghjo
MRMasoumeh Ranjbarzadhag
Masoumeh Ranjbarzadhag
AAAmirhesam Alirezaei
Amirhesam Alirezaei